Clinical Trials Directory

Trials / Conditions / Childhood Infratentorial Ependymoma

Childhood Infratentorial Ependymoma

14 registered clinical trials studyying Childhood Infratentorial Ependymoma.

StatusTrialSponsorPhase
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
CompletedStudy of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial
NCT01407744
Children's Oncology Group—
CompletedSunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or E
NCT01462695
National Cancer Institute (NCI)Phase 2
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi
NCT01076530
National Cancer Institute (NCI)Phase 1
CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
NCT00946335
National Cancer Institute (NCI)Phase 1
CompletedIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
NCT00363272
National Cancer Institute (NCI)Phase 1
CompletedAZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
NCT00326664
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
NCT00100880
National Cancer Institute (NCI)Phase 1
CompletedCollecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
NCT00919750
Children's Oncology Group—
CompletedCilengitide in Treating Children With Refractory Primary Brain Tumors
NCT00063973
National Cancer Institute (NCI)Phase 1
CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
NCT00052780
National Cancer Institute (NCI)Phase 1
CompletedFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
NCT00053963
National Cancer Institute (NCI)Phase 1
CompletedIrinotecan in Treating Children With Refractory Solid Tumors
NCT00004078
Children's Oncology GroupPhase 2